We are offering a number of new imaging capabilities to support toxicology and preclinical studies. There will be an eblast coming out shortly and an update on our webpage. These capabilities include OCT for retinal changes and dermal fibrosis, IVIS imaging, Laser Doppler Imaging (useful for burn circulation assessment), digital radiology, PET scanning, MRI, CT scanning and MicroCT. Please look at the webpage and contact us for more information!
2516
New Preclinical and Toxicologic Imaging Capabilities at CBI
By Admin • October 26, 2015 • CBIRecent Posts
- Intraocular Lens Implantation Preclinical Models at CBI
- Histopathology on Human Muscle Biopsies from patients affected with a Glycogen Storage Disease
- Models of Pulmonary Infection
- Cannabis Preclinical Pharmacology and Toxicology
- CBI Sponsors Ototoxicity and ABRs in Toxicologic Assessments at the ACT